The continued occurrence of primary Pneumocystis carinii pneumonia despite the availability of prophylaxis

被引:7
作者
Klein, MB
Lalonde, RG
机构
[1] MONTREAL CHEST INST,MONTREAL,PQ H2X 2P4,CANADA
[2] ROYAL VICTORIA HOSP,MONTREAL,PQ H3A 1A1,CANADA
[3] MCGILL UNIV,MONTREAL,PQ,CANADA
基金
加拿大健康研究院;
关键词
D O I
10.1093/clinids/24.3.522
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:522 / 523
页数:2
相关论文
共 4 条
[1]  
Centers for Disease Control (CDC), 1989, MMWR Suppl, V38, P1
[2]   PROPHYLAXIS FOR PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS [J].
KOVACS, JA ;
MASUR, H .
CLINICAL INFECTIOUS DISEASES, 1992, 14 (05) :1005-1009
[3]   EFFECT OF ROUTINE USE OF THERAPY IN SLOWING THE CLINICAL COURSE OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION IN A POPULATION-BASED COHORT [J].
LONGINI, IM ;
CLARK, WS ;
KARON, JM .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1993, 137 (11) :1229-1240
[4]   TRENDS IN THE INCIDENCE OF OUTCOMES DEFINING ACQUIRED-IMMUNODEFICIENCY-SYNDROME (AIDS) IN THE MULTICENTER AIDS COHORT STUDY - 1985-1991 [J].
MUNOZ, A ;
SCHRAGER, LK ;
BACELLAR, H ;
SPEIZER, I ;
VERMUND, SH ;
DETELS, R ;
SAAH, AJ ;
KINGSLEY, LA ;
SEMINARA, D ;
PHAIR, JP .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1993, 137 (04) :423-438